Market News Call

Just In: Celgene Corporation (NASDAQ:CELG), Incyte Corporation (NASDAQ:INCY)

UBS initiates Celgene Corporation(NASDAQ:CELG) with a Buy and price target of $140. Robust top-line growth has become a rarity in large-cap biotech, and against that backdrop, Celgene has and should continue to stand out


Quick News: Celgene Corporation (NASDAQ:CELG), Corcept Therapeutics Incorporated (NASDAQ:CORT)

Celgene Corporation(NASDAQ:CELG) announces the formation of a consortium for the purpose of accelerating the discovery & development of cancer therapeutics/diagnostics, paid $50 mln in total to each institution for the option to enter into


Volume Buzz: CTI BioPharma Corp. (NASDAQ:CTIC), Amgen Inc. (NASDAQ:AMGN), Celgene Corporation (NASDAQ:CELG)

Lakeway, NY — (MARKET NEWS CALL) — 19/02/2016— Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market about the small and penny stocks, issues


Latest Developments: Mast Therapeutics Inc (NYSEMKT:MSTX), Gilead Sciences Inc. (NASDAQ:GILD), Celgene Corporation (NASDAQ:CELG)

Lakeway, NY — (MARKET NEWS CALL) — 10/02/2016— Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market about the small and penny stocks, issues